Trial · NCT01799889
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | CLL: Entospletinib MM/SDD | 41 | |
| Overall Study | STARTED | FL: Entospletinib MM/SDD | 41 | |
| Overall Study | STARTED | DLBCL: Entospletinib MM/SDD | 44 | |
| Overall Study | STARTED | MCL: Entospletinib MM/SDD | 39 | |
| Overall Study | STARTED | Non-FL iNHL: Entospletinib MM/SDD | 49 | |
| Overall Study | STARTED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 100 mg | 20 | |
| Overall Study | STARTED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 200 mg | 21 | |
| Overall Study | STARTED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 400 mg | 20 | |
| Overall Study | STARTED | CLL (Non-Richters) Prior BTK Inhibitor: Entospletinib SDD | 33 | |
| Overall Study | STARTED | CLL (Non-Richters) Prior PI3K Inhibitor: Entospletinib SDD | 8 | |
| Overall Study | STARTED | CLL (Richters) Prior BTK Inhibitor: Entospletinib SDD | 7 | |
| Overall Study | STARTED | CLL (Richters) Prior PI3K Inhibitor: Entospletinib SDD | 3 | |
| Overall Study | COMPLETED | CLL: Entospletinib MM/SDD | 0 | |
| Overall Study | COMPLETED | FL: Entospletinib MM/SDD | 0 | |
| Overall Study | COMPLETED | DLBCL: Entospletinib MM/SDD | 0 | |
| Overall Study | COMPLETED | MCL: Entospletinib MM/SDD | 0 | |
| Overall Study | COMPLETED | Non-FL iNHL: Entospletinib MM/SDD | 0 | |
| Overall Study | COMPLETED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 100 mg | 0 | |
| Overall Study | COMPLETED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 200 mg | 0 | |
| Overall Study | COMPLETED | CLL, Prior BCR Inhibitor Naive: Entospletinib SDD 400 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01799889/flow